Xspray Pharma AB (publ) filed its Annual on Mar 29, 2023 for the period ending Dec 31, 2022. In this report its auditor, KPMG LLP - Klynveld Peat Marwick Goerdeler, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
78.1 SEK | -1.76% |
|
-2.50% | +95.25% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+95.25% | 255M | |
+19.44% | 124B | |
+20.01% | 114B | |
+21.11% | 25.83B | |
-23.72% | 19.42B | |
-18.17% | 16.2B | |
-19.87% | 15.31B | |
+55.81% | 14.32B | |
+8.76% | 14.31B | |
-48.79% | 14.19B |
- Stock Market
- Equities
- XSPRAY Stock
- News Xspray Pharma AB
- Xspray Pharma AB Auditor Raises 'Going Concern' Doubt